Diabetes, especially Type 2, affects millions of people globally, and new drug developments have completely changed how it is managed. Because Farxiga and Invokana belong to a unique class of drugs known as SGLT2 inhibitors, they have become more well-known. These medications lower blood sugar levels by helping the kidneys remove excess glucose, or sugar, from the body.
In addition to providing additional health benefits including lowering blood pressure and helping with weight control, SGLT2 inhibitors are a promising development in the treatment of diabetes. Having effective treatment options is essential because Type 2 diabetes is so common. In fact, it is estimated that this disorder affects about 37 million Americans, and its prevalence is rising globally.
The differences between Farxiga and Invokana will be examined in this post to help you understand each medication’s advantages and disadvantages. Knowing this information will help you and your healthcare practitioner make an informed decision about which drug might work best for you.
Understanding Both Medications
Farxiga (Dapagliflozin)
Dapagliflozin, another name for farxiga, is a prescription medication that helps people with Type 2 diabetes lower their blood sugar levels. Farxiga belongs to the class of SGLT2 inhibitors and works by blocking sodium-glucose co-transporter 2, a kidney protein. This process allows the body to eliminate glucose through urine by preventing its absorption back into the bloodstream.
Farxiga is usually used once a day, usually in the morning, by most people. Depending on individual needs, dosages might vary; many people start with a lower dosage and adjust as needed.
Invokana (Canagliflozin)
Another kind of SGLT2 inhibitor is invokana, also referred to as canagliflozin. Like Farxiga, Invokana prevents the kidneys from reabsorbing glucose, which results in its excretion in urine. Variations in the chemical makeup of invokana may affect how well it functions in the body.
Similar to Farxiga, Invokana is typically taken once daily at a similar starting dosage, which a medical practitioner may adjust if needed.
Shared Features
Both Invokana and Farxiga help reduce blood sugar levels and some of the dangers related to diabetes. Both are taken orally as tablets and work similarly to remove glucose from the body. We’ll go into further detail about these drugs’ comparable benefits and limitations.
Cardiovascular and Kidney Benefits
According to recent studies, Farxiga and Invokana offer additional health benefits beyond controlling blood sugar levels, particularly for the kidneys and heart. According to a research published in the New England Journal of Medicine, Farxiga significantly lowers the risk of heart failure hospitalization and slows the progression of kidney disease in those with or without diabetes. For those who have chronic kidney problems or cardiac disease, this is an appealing option. Similarly, research has shown that Invokana can lower the risk of heart-related disorders, such as heart attacks, in those with Type 2 diabetes, supporting its appropriateness for patients who are at high risk of cardiovascular complications.
Updates on Safety Profiles and Side Effects
New findings have also provided more insight into these medications’ safety. Urinary tract infections brought on by elevated urine glucose levels are among the common side effects of farxiga and invokana. However, new studies show that these risks can be effectively managed with proper hydration and constant observation. In particular, Invokana is associated with a marginally increased risk of lower limb amputations in some patients, however this risk is rare and mostly affects those who already have diseases like neuropathy. For a safer and more individualized treatment plan, patients should discuss their entire medical history with their healthcare professional in order to weigh the benefits and drawbacks of each prescription.
Effectiveness Comparison
Blood Sugar Control
According to clinical research, Invokana and Farxiga successfully lower blood sugar levels. They help reduce the A1C, a crucial metric that shows the average blood sugar level over a three-month period. Depending on individual circumstances, both medications can lower A1C levels by an average of 0.7% to 1%.
Invokana and Farxiga also help lower fasting blood sugar, which is crucial for blood sugar management in general.
Additional Benefits
Beyond controlling blood sugar levels, Farxiga and Invokana offer additional health benefits. While Invokana has been acknowledged for its benefits in reducing cardiovascular risks including heart attacks and strokes, studies have shown that Farxiga can reduce the risk of heart failure in diabetic people.
According to study, Farxiga and Invokana may both lead to a modest decrease in body weight. The body expels calories through the excretion of glucose, which contributes to this weight reduction. Additionally, both medications help lower blood pressure, which benefits the cardiovascular system even more.
Speed of Action
Both Invokana and Farxiga begin to work really quickly after ingestion. The effect on blood sugar levels is usually seen within the first week, and after a few weeks of use, patients may notice more consistent outcomes. The exact onset and duration of the impact depend on a number of factors, including food, individual reaction, and other drugs.
Safety Profiles
Common Side Effects
Like any medications, Invokana and Farxiga have possible adverse effects. Due to the removal of extra glucose from the body, these drugs frequently result in increased urine. For some people, elevated urine glucose can also lead to an increased risk of yeast infections and urinary tract infections (UTIs).
Serious Side Effects
Both drugs have serious side effects, however they are rare. Farxiga and Invokana can increase the risk of diabetic ketoacidosis (DKA), a condition that happens when the body produces too many ketones because there is not enough insulin in the blood. The illness may manifest as nausea, vomiting, and stomach pain, all of which call for immediate medical attention.
Additionally, Invokana has been associated with increased risk of bone fractures and, in some studies, a higher risk of lower limb amputations. Though rare, this danger should be discussed with a healthcare provider, especially for those who have underlying medical issues that may increase the risk.
Warnings and Updates
Both Invokana and Farxiga have received safety updates from the . The dangers described above and the requirement for regular renal monitoring are included in these updates. Since both of these drugs depend on healthy kidneys to work, maintaining renal health is crucial when taking them.
Specific Patient Considerations
Medical History Factors
Your medical history plays a major role in determining whether Farxiga or Invokana is the best drug for you. For example, these drugs might not be safe for use by people with certain kidney conditions. When taking any of the drugs, it is essential to have regular kidney function tests.
Lifestyle Considerations
A person’s daily routine could be impacted by both Farxiga and Invokana. They cause frequent urination, therefore it’s important to stay properly hydrated throughout the day. Additionally, to help with weight control and the general management of diabetes, these drugs should be taken in combination with a healthy diet and regular exercise for best benefits.
Cost and Accessibility
Even if Farxiga and Invokana are widely available, costs could be a concern. It’s best to check with your insurance provider because some policies may cover one medication but not another. Another way to lower the cost of these drugs is through patient assistance programmes.
Special Populations
Elderly Patients
When using Invokana or Farxiga, older people may need to consider certain issues. Elderly people need to closely monitor their fluid intake because they may be more susceptible to dehydration as a result of the frequent urine these drugs produce.
Patients with Kidney Disease
Since both Farxiga and Invokana rely on renal function to remove glucose, people with certain kidney disorders may need to avoid them or use lower dosages. Regular renal tests are necessary for monitoring individuals using either medication in order to guarantee safety.
Cardiovascular Disease Patients
For people with heart issues, Farxiga and Invokana offer additional benefits. While Invokana may reduce the risk of some cardiovascular events including heart attacks, Farxiga has shown promising results in reducing the likelihood of heart failure. These extra benefits might be helpful for people with heart problems.
Practical Usage Guidelines
Taking the Medication
It is standard practice to take Invokana with Farxiga once a day, usually in the morning, with or without meals. Proper medicine administration requires adherence to the doctor’s recommendations; missing doses should only be done when advised.
Monitoring Requirements
People who are prescribed Invokana or Farxiga should regularly monitor their kidney function and blood sugar levels. To ensure that the drug is safe for you and functioning as intended, your doctor might advise routine laboratory testing.
Making the Choice
The choice between Farxiga and Invokana depends on personal factors such as lifestyle, health history, and desired benefits in a diabetes therapy. Speaking with your healthcare practitioner will help you understand which drug might be better for your needs. Discuss your goals, your risk-taking propensity, and how each decision may affect your daily schedule.
Conclusion
The choice between Farxiga and Invokana depends on personal factors such as lifestyle, health history, and desired benefits in a diabetes therapy. Speaking with your healthcare practitioner will help you understand which drug might be better for your needs. Discuss your goals, your risk-taking propensity, and how each decision may affect your daily schedule.
365scriptcare.com is an established pharmacy referral service. Order brand name and generic equivalent drugs online from a trusted Canadian drug source. Log onto www.365scriptcare.com to see how you can buy discounted drug prices shipped to the USA from Canada.